3SBio climbs 5%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

3SBio (1530.HK) climbed more than 5% in Hong Kong trading to HK$14.69.

The stock is up 7.30% over the past five sessions and down 38.61% year to date.

The Hang Seng Index is up 3.09% over the past five sessions and down 7.11% year to date.

The biotechnology industry index rose 7.1% over the same period.

Key drivers include the out-licensing of SSGJ-707 to Pfizer, strong R&D capabilities and undervalued Phase II clinical assets.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.